Polymorphisms within intron 2 of the Igf2bp2 gene influence type 2 diabetes risk [18], [19], [20], [21] and have been linked to reduced early phase insulin release and other indices of impaired pancreatic beta cell function [22], [23], [24]. Here, IGF2BP2 is linked to type 2 diabetes mellitus.